Ireland· IE-PA-PA1347/058/002
Septanazal 1 mg/ 50 mg in 1 ml nasal spray solution
A xylometazoline product containing xylometazoline hydrochloride + dexpanthenol, registered in Ireland by KRKA, d.d., Novo mesto. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Xylometazoline is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Xylometazoline · ATC R01AB06
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Xylometazoline hydrochloride + Dexpanthenol
- Manufacturer
- KRKA, d.d., Novo mesto
- Country
- Ireland (IE)
- ATC code
- R01AB06
- ATC class
- Xylometazoline
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1347/058/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for xylometazoline.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Xylometazoline · interactions on record
63 records
- 6 severe
- 54 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- MethysergideN02CA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Xylometazoline in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandNasicM.C.M. Klosterfrau Healthcare Sp. z o.o.
- CzechiaNASICCassella-med GmbH & Co. KG, Kolín nad Rýnem
- SwitzerlandAmavita Xylo Plus Nasenspray, LösungAmavita Health Care AG
- GermanyNasenduo KinderRatiopharm Gmbh
- SpainFRENASAL PLUS 1 MG/ML + 50 MG/ML SOLUCION PARA PULVERIZACION NASALJntl Consumer Health (Spain) S.L.
- FinlandSeptanazalKRKA d.d. Novo mesto
- United KingdomSudafed Plus Blocked Nose 1mg/ml / 50mg/ml nasal sprayMcNeil Products Ltd
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Nasic, Nasic Pur
- Bulgaria · Nasic назик, Ксилазол
- Cyprus · Hexarhinal Plus, Hexarhinal Plus Kids
- Czechia · Nasic, Olynth Plus
- Germany · Nasenduo Kinder, Nasic
- Denmark · Zymelin Care
- Estonia · Otrinazil, Septanazal
- Spain · Septanasal
- Finland · Septanazal
- United Kingdom (Northern Ireland) · Sudafed Plus Blocked Nose
- Greece · Hexarhinal Plus, Hexarhinal Plus Kids
- Croatia · Ksilometazolin/Dekspantenol Pliva, Nasic
- Hungary · Actifed, Actifed Kid
- Lithuania · Galathenal, Olydex
- Luxembourg · Nasenduo Nasenspray Kinder, Xyloduo Nasenspray
- Latvia · Galathenal, Olydex
- Malta · Septanazal
- Norway · Xylodex
- Poland · Nasic, Otrivin Regeneracja
- Portugal · Nasex Duo, Septanazal Para Adultos
- Romania · Bixtonim Xylo Duo, Nasic
- Slovenia · Nasic, Olynth Combo
- Slovakia · Nasal Duo Active, Nasic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae816a58-47d9-4b37-a7ed-b6010806736f GET /v1/drugs/ae816a58-47d9-4b37-a7ed-b6010806736f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nasal spray, solution",
"routes": [
"Nasal use"
],
"source": "hpra",
"atc_all": [
"R01AB",
"R01AB06"
],
"strength": null,
"pa_number": "PA1347/058/002",
"substances": [
"Xylometazoline hydrochloride",
"Dexpanthenol"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "02/12/2016",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about xylometazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.